Julianne Lwanga

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison Rodger, Valentina Cambiano, Tina Bruun et al. · The Lancet · 2019 · 998 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

Sarah Fidler, Wolfgang Stöhr, Lucy Dorrell et al. · The Lancet · 2020 · 138 citations

Public Health, Infectious Disease Control, Pharmacotherapy +14

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

Geneviève Martin, Matthew Pace, John Thornhill et al. · Frontiers in Immunology · 2018 · 44 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Feasibility randomized‐controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study

Whitney Scott, Beth J Guildford, James Badenoch et al. · European Journal of Pain · 2021 · 34 citations · Full text

Medicine, Health Behavior, Outcomes Research +16

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Chloe Orkin, Jean‐Michel Molina, Pedro Cahn et al. · The Lancet HIV · 2023 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15